Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 451 AL 465

[Pro-inflammatory cytokines in Alzheimer's disease]

Stamouli EC, Politis AM.

Psychiatriki. 2016 Oct-Dec;27(4):264-275. doi: 10.22365/jpsych.2016.274.264.

A comparison of the cluster-span threshold and the union of shortest paths as objective thresholds of EEG functional connectivity networks from Beta activity in Alzheimer's disease

Smith K, Abasolo D, Escudero J.

Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:2826-2829. doi: 10.1109/EMBC.2016.7591318.

Amyloid-beta immunotherapy: the hope for Alzheimer disease?

Barrera-Ocampo A, Lopera F.

Colomb Med (Cali). 2016 Dec 30;47(4):203-212.

Traumatic brain injury: a risk factor for neurodegenerative diseases

Gupta R, Sen N.

Rev Neurosci. 2016 Jan;27(1):93-100. doi: 10.1515/revneuro-2015-0017.

Non-Pharmacological Approaches to the Prevention and Treatment of Alzheimer's Disease with Respect to the Rising Treatment Costs

Klimova B, Maresova P, Kuca K.

Curr Alzheimer Res. 2016;13(11):1249-1258. doi: 10.2174/1567205013666151116142302.

A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians

Steenland K, Goldstein FC, Levey A, Wharton W.

J Alzheimers Dis. 2016;50(1):71-6. doi: 10.3233/JAD-150778.

Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease

Somavarapu AK, Kepp KP.

J Neurochem. 2016 Apr;137(1):101-11. doi: 10.1111/jnc.13535. Epub 2016 Feb 11.

Prevalence of Comorbidity in Patients With Young-Onset Alzheimer Disease Compared With Late-Onset: A Comparative Cohort Study

Gerritsen AA, Bakker C, Verhey FR, de Vugt ME, Melis RJ, Koopmans RT; 4C study team.

J Am Med Dir Assoc. 2016 Apr 1;17(4):318-23. doi: 10.1016/j.jamda.2015.11.011. Epub 2016 Jan 5.

[Prevention of Alzheimer's dementia in Germany : A projection of the possible potential of reducing selected risk factors]

Luck T, Riedel-Heller SG.

Nervenarzt. 2016 Nov;87(11):1194-1200. doi: 10.1007/s00115-015-0045-1.

Meta-analysis of BACE1 gene rs638405 polymorphism and the risk of Alzheimer's disease in Caucasion and Asian population

Yu M, Liu Y, Shen J, Lv D, Zhang J.

Neurosci Lett. 2016 Mar 11;616:189-96. doi: 10.1016/j.neulet.2016.01.059. Epub 2016 Jan 30.

The Human Alzheimer Disease Project: Answering the Call

DeKosky ST, Growdon JH.

JAMA Neurol. 2016 Apr;73(4):373-4. doi: 10.1001/jamaneurol.2015.4512.

Inhalational Alzheimer's disease: an unrecognized - and treatable - epidemic

Bredesen DE.

Aging (Albany NY). 2016 Feb;8(2):304-13. doi: 10.18632/aging.100896.

Health-Related Quality of Life in Patients with Alzheimer's Disease in Different German Health Care Settings

Heßmann P, Seeberg G, Reese JP, Dams J, Baum E, Müller MJ, Dodel R, Balzer-Geldsetzer M.

J Alzheimers Dis. 2016;51(2):545-61. doi: 10.3233/JAD-150835.

Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease

Singhrao SK, Harding A, Chukkapalli S, Olsen I, Kesavalu L, Crean S.

J Alzheimers Dis. 2016;51(4):935-48. doi: 10.3233/JAD150690.

Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer's disease (Review)

Feng R, Li L, Yu H, Liu M, Zhao W.

Mol Med Rep. 2016 Apr;13(4):3397-400. doi: 10.3892/mmr.2016.4966. Epub 2016 Mar 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias